Modulation of organ uptake of 11C-labelled L-DOPA

Nuclear Medicine and Biology

Volumn 24, Issue 1, 1997, Pages 15-19

  Bergström, Mats ^a   Lu, Li ^a   Marquez, Marcela ^a   Fasth, Karl Johan ^a   Bjurling, Peter ^a   Watanabe, Yasuyoshi ^a,b   Eriksson, Barbro ^c   Långström, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

aromatic amino acid decarboxylase; COMT; L DOPA; monoamine oxidase; pancreas; positron emission tomography

Indexed keywords

BENSERAZIDE; CARBIDOPA; CLORGYLINE; DECARBOXYLASE INHIBITOR; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; SELEGILINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; PANCREAS; POSITRON EMISSION TOMOGRAPHY; RAT;

EID: 0030898461     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00149-7     Document Type: Article

References (20)

1. Ahlström H., Eriksson B., Bergström M., Bjurling P., Långström B. and Öberg K. (1995) Pancreatic neuroendocrine tumors: Diagnosis with PET. Radiology 195, 333-337.
2. 11C-dopamme. J. Nucl. Med. 37, 32-37.
3. 11C-labelled L-tyrosine, L-DOPA, L-tryptophan and 5-hydroxy-L-tryptophan. Acta Chem. Scand. 44, 178.
4. 11C-labelled analogues of L-tyrosine and L-tryptophan. J. Label. Compd. Radiopharm. 30, 399.
5. 11C-labelled L-tyrosine and L-DOPA. Acta Chem. Scand. 44, 183.
6. 11C-labelled L-tryptophan and 5-hydroxy-L-tryptophan using a multi-enzymatic reaction route. J. Chem. Soc. Perkin Trans. 1, 1331.
7. Eriksson B., Bergström M., Lilja A., Ahlström H., Långström B. and Öberg K. (1993) Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors. Acta Oncol. 32, 189-196.
8. Eriksson B., Lilja A., Ahlström H., Bjurling P., Bergström M., Lindner K. J., Långström B. and Öberg K. (1994) Positron emission tomography as a radiological technique in neuroendocrine gastrointestinal tumors. In: Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease (Edited by Wiedenmann B., Kvols L. K., Arnold R. and Riecjken E.-O.), pp. 446-452, Vol. 733. Ann. N.Y. Acad. Sci.
9. 11C]harmine in frozen-section autoradiography. Oncol. Rep. 2, 717-721.
10. 18F]fluoro-L-dopa in rhesus monkey. Nucl. Med. Biol. 22, 921-927.
11. 11C]-L-DOPA following COMT inhibition: A study in vivo using positron emission tomography. J. Neural. Transm. 87, 15-22.
12. Karhunen T., Tilgmann C., Ulmanen I., Julkunen I. and Panula P. (1994) Distribution of catechol-O-methyltransferase enzyme in rat tissues. J. Histochem. Cytochem. 42, 1079-1090.
13. Lindner K. J., Hartvig P., Tyrefors M., Hedlund C. and Långström B. (1995) An automated liquid chromatographic plasma analysis of amino acids used in combination with positron emission tomography (PET) for determination of in vivo plasma kinetics. J. Pharm. Biomed. Anal. 13, 353-359.
14. Männisto P. T., Kaakola S., Nissinen E., Linden I. B. and Pohto P. (1988) Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase. Life Sci. 43, 1465-1471.
15. Nissinen E., Lindén I. B., Schultz E., Kaakola S., Männisto P. T. and Pohto P. (1988) Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. Eur. J. Pharmacol. 153, 263-269.
16. Owman C., Håkanson R. and Sundler F. (1973) Occurrence and function of amines in endocrine cells producing polypeptide hormones. Fed. Proc. 32, 1785-1791.
17. 18F]fluoro-L-dopa. Eur. J. Pharmacol. 257, 53-58.
18. Pearse A. L. E. (1980) The APUD concept and hormone production. Clin. Endocrinol. Metab. 17, 211-222.
19. 18F]-6-L-fluorodopa metabolism: Implications for levodopa therapy of Parkinson's disease. Neurology 44, 1292-1297.
20. 3H)-labelled ligands visualized by imaging plates. NeuroReport 3, 961-964.